Straumann Group Reports 7.1% Organic Growth in Q1 2026

Straumann Group announced a strong start to 2026 with a 7.1% organic growth in revenue, totaling CHF 673 million for the first quarter. The growth was evenly distributed across regions, driven by robust performance in implantology, digital integration through the Straumann AXS platform, and orthodontic advancements. Despite foreign exchange challenges, the group's broad execution strategy underpinned regional revenue increases, notably in EMEA and LATAM, despite a dip in APAC due to China's economic conditions.

In EMEA, growth reached 7.8% owing to increased demand across major markets and the ongoing success of the iEXCEL implant system. North America showed 7.7% growth, powered by digital solutions and partnerships. Meanwhile, LATAM experienced a 19.5% growth, benefiting from adoption in digital orthodontal solutions.

The group's strategic priorities are on track, with anticipated high single-digit organic revenue growth and EBIT margin improvements in 2026. CEO Guillaume Daniellot attributes this success to strategic execution, innovation, and proactive customer engagement.